Some pharmacologic characteristics of a new antihistaminic (SQ 10,648), 11-(2-dimethylaminoethyl)-6,11-dihydrodibenz-[b,e] [1,4] oxazepine maleate.
D000707:Anaphylaxis / Q000188:drug therapy*; D000818:Animals; D001522:Behavior, Animal; D001794:Blood Pressure / Q000187:drug effects; D001980:Bronchi / Q000187:drug effects; D004285:Dogs; D004562:Electrocardiography; D005745:Gastric Acidity Determination; D005750:Gastric Juice; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D006632:Histamine / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology* / Q000627:therapeutic use* / Q000633:toxicity; D066298:In Vitro Techniques; D008635:Mescaline / Q000494:pharmacology; D051379:Mice; D009130:Muscle, Smooth / Q000187:drug effects; D051381:Rats; D012119:Respiration / Q000187:drug effects; D012701:Serotonin / Q000494:pharmacology; D013270:Stomach / Q000187:drug effects
D006634:Histamine H1 Antagonists; D012701:Serotonin; D006632:Histamine; D008635:Mescaline